Earnings Estimates Moving Higher for Docebo (DCBO): Time to Buy?

Docebo's current-quarter EPS estimate was raised to $0.33, up 22.2% year over year, while the full-year estimate rose to $1.69, up 22.5% YoY. Over the last month, three current-quarter estimates and four full-year estimates moved higher, pushing consensus up 8.93% and 16.01%, respectively. The stock has already gained 9.6% over the past four weeks, and Zacks now rates Docebo a #1 (Strong Buy).

Analysis

DCBO’s upgrade momentum is less about the absolute earnings level and more about the rate of change in expectations, which tends to matter most for software multiples over the next 1-2 reporting cycles. In a market that is still rewarding “proof of re-acceleration,” even modest upward revisions can compress the discount rate on future growth and pull forward valuation expansion before the fundamentals are fully visible in the reported numbers.

The second-order beneficiary is not just DCBO’s equity beta but the broader SaaS basket: stronger estimates for one mid-cap software name often signal that budget scrutiny is easing at the margin, which can lift sentiment across adjacent vertical SaaS and HCM/CRM names. The risk is that revision breadth may be more technical than durable—if the next print shows slower net-new demand, longer sales cycles, or elongated billings conversion, the market can unwind the multiple expansion quickly because estimate-led rallies are usually most fragile in the 30-90 day window.

Consensus appears to be missing how crowded this type of trade can become once a stock is already up sharply in a month. That creates a positive reflexivity loop in the near term, but also increases vulnerability to any guidance that merely meets rather than exceeds the now-lifted bar. The key question is whether revisions reflect genuine end-demand improvement or just normalization after a soft period; in SaaS, those are very different regimes, and only the former supports a multi-quarter rerating.

Key Decisions for Investors

• Go long DCBO for a 2-6 week momentum/revisions trade, but size modestly because the setup is consensus-friendly and prone to air pockets after the next earnings event; treat 8-12% upside as base case and use a 6-8% trailing stop.
• Express the view with DCBO call spreads rather than outright equity if implied vol is reasonable; this keeps premium defined while capturing a continuation move over the next 1-2 months.
• Pair long DCBO / short a lower-quality SaaS peer with deteriorating estimate revisions to isolate the revisions factor; the trade should work best if software multiples stay stable and investors continue rewarding upward estimate drift.
• If you are already long, trim into strength after a further 1-2 weeks of follow-through, since revision-driven rallies often peak before the actual earnings confirmation arrives.
• Do not chase if the stock gaps materially higher on no new fundamentals; wait for a pullback to the 20-day trend or post-earnings confirmation, because the asymmetry shifts once the market has fully repriced the revisions story.